Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms
- 24 August 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Endocrinology & Metabolism
- Vol. 13 (5) , 251-262
Abstract
Introduction: Cardiovascular and renal disease accounts for a substantial proportion of the morbidity and mortality associated with obesity and type 2 diabetes mellitus (T2DM). Bariatric surgery is associated with improved long-term cardiovascular and renal outcomes. Areas covered: All major case-control, cohort, and randomized controlled trial studies of bariatric surgery in adults with T2DM were screened and data on prespecified cardiovascular and renal outcomes collated. Bariatric surgery reduces all-cause mortality and risk of cardiovascular disease, albuminuria and progressive chronic kidney disease. Patients with poorer glycemic control and established microvascular disease preoperatively may stand to benefit the most from the surgical approach. Reduced sympathetic drive, remission of glomerular hypertension, enhanced natriuresis, gut microbiota shifts, reduced systemic and renal inflammation, improved lipoprotein profiles, and reductions in chronic cardiac remodeling may all be implicated. Expert commentary: Ongoing RCTs of bariatric surgery selectively recruiting patients with class 1 obesity and established microvascular complications of diabetes will help to better characterize which subgroups of patients benefit most from this effective therapy.Keywords
Funding Information
- not funded
This publication has 102 references indexed in Scilit:
- Gastric Bypass Surgery Is Followed by Lowered Blood Pressure and Increased Diuresis - Long Term Results from the Swedish Obese Subjects (SOS) StudyPLOS ONE, 2012
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- The Link Between the Renin-Angiotensin-Aldosterone System and Renal Injury in Obesity and the Metabolic SyndromeCurrent Hypertension Reports, 2012
- Epidemiology and risk profile of heart failureNature Reviews Cardiology, 2010
- Neprilysin, obesity and the metabolic syndromeInternational Journal of Obesity, 2010
- Obesity-induced Hypertension: Role of Sympathetic Nervous System, Leptin, and MelanocortinsJournal of Biological Chemistry, 2010
- Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney DiseaseAmerican Journal of Nephrology, 2010
- Adiponectin regulates albuminuria and podocyte function in miceJournal of Clinical Investigation, 2008
- Cardiac Remodeling in ObesityPhysiological Reviews, 2008
- Cystatin C and risk of heart failure in the Physicians' Health Study (PHS)American Heart Journal, 2008